chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Info has been received from a registered nurse concerning a 69 year old female pt who on 10/17/2002 was vaccinated with the "first documented" dose of pneumococcal vaccine 23 polyvalent (lot #641531/1352L). Subsequently the pt had a local reaction at injection from shoulder to elbow, red and blister-like. The pt sought medical attention and was treated with dephenhydramine HCl (Benadryl). It was reported that the symptoms resolved. It was also reported that 2 other patients (WAES #0211USA01411 and 0211USA01412) experienced symptoms after vaccination with pneumococcal vaccine 23 polyvalent. Additional info has been requested.
Information has been received from a 22 year old female, who on February 2008 and April 2008, was vaccinated with the first and second doses, respectively, of GARDASIL. Concomitant therapy included ethinyl estradiol (+) etonogestrel (NUVARING). in April 2008, after receiving the second dose of GARDASIL, the patient went up to make her neck appointment and started to faint. So the office had her sat down in a chair and gave her some water. The patient reported that she started to lose consciousness, but never fully did, but she sat for 15 minutes and was able to leave the office after the 15 minutes. It was reported that the patient recovered. She was scheduled to get the third dose of GARDASIL in August 2008. Additional information has been requested.
bad reaction on his arm; could not sleep on it; lock jaw on the left side of face; fever of 101.5; swollen glands; This spontaneous case was reported by a health care professional and describes the occurrence of INJECTION SITE REACTION (bad reaction on his arm), INSOMNIA (could not sleep on it), TRISMUS (lock jaw on the left side of face), PYREXIA (fever of 101.5) and LYMPHADENOPATHY (swollen glands) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0126ZOA) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis (Patient had Rheumatoid Arthritis for a couple of years but was in remission, hence he was not taking any medication for it. But the second dose of the vaccine made his Rheumatoid Arthritis worse again, could not walk because his toes and fingers hurt. All his blood work for the rheumatoid markers were elevated.).    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE REACTION (bad reaction on his arm), INSOMNIA (could not sleep on it), TRISMUS (lock jaw on the left side of face), PYREXIA (fever of 101.5) and LYMPHADENOPATHY (swollen glands). At the time of the report, INJECTION SITE REACTION (bad reaction on his arm), INSOMNIA (could not sleep on it), TRISMUS (lock jaw on the left side of face), PYREXIA (fever of 101.5) and LYMPHADENOPATHY (swollen glands) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medication information was reported.   This case was linked to MOD-2021-058201 (Patient Link).
numbness in her left leg/ numbness in her left arm down to fingers/more numbness on the right side; tongue has been numb; really feel weird on her face; burning sensation that shot across the top of her left ear and nose/burning sensation down the left side of her body; left side of her face started to feel hot; This is a spontaneous report from a contactable consumer (patient).   A 58-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot Number: ER8735) via an unspecified route of administration, administered in Arm Left,  at the age of 58-year-old, on 31Mar2021 18:45 as SINGLE DOSE for covid-19 immunisation.  Medical history was none. There were no concomitant medications. On 31Mar2021, a half an hour later, as the patient was driving home, the left side of her face started to feel hot and she kept putting her right hand on it to cool it off. The patient got a burning sensation that shot across the top of her left ear and nose. Once at home, she started to really feel weird on her face, and she had a burning sensation down the left side of her body. Her face felt strange for 1 hour and then declined. The patient went to bed at 09:30P.M. and she noticed numbness in her left leg. The next morning, the numbness in her left leg was much worse and she had numbness in her left arm down to fingers. States she called the doctor when they opened at 09:00 A.M. and they said to go to the ER right away because of all the numbness. The ER treated her like a stroke patient, and  wanted to make sure she didn't have a stroke so she had a full MRI, Cat Scan, and Bloodwork done that all came back normal. The patient was in the ER on 01Apr2021 morning and she was admitted for observation and she came out of the hospital 02Apr2021 before 5:00P.M. The doctor ordered more bloodwork and a CT with contrast was ordered for her spine to see if she has any spinal damage. The patient saw a neurologist on 05Apr2021, she has had more numbness on the right side. Clarified that her right foot feels numb intermittently along with the right side of her face. Her tongue has been numb on 31Mar2021, like a line across it, most of the time. The numbness ebbs and flows and where she feels it,  moves around. It is not as strong as a week ago but it moves around. No treatment was given in response to the events. She stated the neurologist and no one has recommendations on if she should receive the second dose. Outcome of left side of her face started to feel hot, really feel weird on her face was recovering; tongue has been numb was not recovered;Burning sensation recovered on 31Mar2021, numbness in her left leg/ numbness in her left arm down to fingers/more numbness on the right side was unknown.  Follow-up attempts are completed. No further information is expected.
Aches, inflammation of lymph notes, and higher than normal heart rate for myself (resting heart rate is high 80s to 90; sometimes over 100.  Doing chores around the house can bring it up to 130.  I am physically fit, so this is abnormal heart rate for me. Currently, monitoring my heart rate.
Approximately 10 hours after receiving the dose I received extreme chest pain, tightness and intense heart beating that felt similar to a heart attack. This lasted until the morning (6am).  From that morning and for one month after, I felt a pain in my chest, where my heart is located. The pain intesified with mold walking and standing. Any mild physical activity also led to shortness of breath and extreme fatigue - needing to stop the activity (such as walking).   Menstral cycle: the first period due after the vaccine (august) was missed. The next period In September was only 2 days (my period are usually 4-5 days). The October period was also missed.
The next day patient experienced difficulty walking  / standing due to pain and extreme weakness, reported blood in urine, extreme fatigue and has since had multiple tests showing decreased WBC counts. Patient is now followed by hematology/oncology.
Respiratory distress at slightest exertion. Normal morning hike the day after first dose of vaccine caused nearly asthmatic reaction. Rescue inhaler prescribed by "doctor"  to make symptoms subside at onset. That worked, but no diagnosis for underlying condition. After several months of misery and fear, my new health care provider NP, determined ongoing allergic or similar reaction and cleared it up with a 5-day steroidal regimen. Now over five weeks hence and symptoms/condition remains resolved.
she did have a little bit of burst of an allergy with the first shot; This is a spontaneous report from a contactable consumer (patient). A 68-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EL3249), via an unspecified route of administration, administered in Arm Left on 14Jan2021 14:30 as 1st dose, single dose for COVID-19 immunization in an public health department. Family history for the patient's dad had 5 heart bypass surgery and a stroke about 7-9 years after. Then 9 years later another stroke that was fatal and the patient's mother had a whole bunch stents but no open heart surgery. The patient's concomitant medications were not reported. No prior vaccinations within 4 weeks. No tests were done. On 18Jan2021, 4 days after the first dose, the patient had little bit of burst of an allergy, she stated she had a rash all over her body, it was not really heavy but was there. The patient visited the emergency room and the doctor told her that it would last 3-4 days and should go away with Benadryl and it cleared up. No physician's office visit was done. The outcome of the events was recovered in 2021.
Pt recvd DTP/OPV/HIB & 12-18 hrs post vax exp drop attack w/unresponsive & not breathing for a few sec; Then came around & was fine; PE in MD totally nl;
Before vaccination I was experiencing slight  sciatica pain in right lower back and buttock.  The morning (6:00 am)after the vaccination I got up and could hardly walk because of excruciating pain in right lower back and buttock.  I started taking a muscle relaxant and Ibuprofen for the pain.  Some days were better than others and after a week I started feeling better with no pain.  I also had right wrist pain (I had surgery on my right wrist Dec/ 31, 2020 for a cyst removal.)  I had trouble moving my right wrist.  I still have some wrist pain, especially in the morning.  It subsides somewhat after using it during the day.  My lips started peeling a couple of days after the vaccination. I used a lip balm several times daily It took a week for my lips to return to normal.  I am feeling well now and am glad to have received the vaccination.
an unspecified 5 year old patient was inadvertently administered a dose of PROQUAD intramuscularly rather than subcutaneously; No adverse effects were reported in the message; This spontaneous report was received from a physician, referring to a 5 year old patient of unknown gender. The patient's pertinent medical history, concomitant medications, concurrent conditions, and drug reactions or allergies were not reported.  On an unknown date,  the patient was vaccinated with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) for prophylaxis, this dose was inadvertently administered intramuscularly rather than subcutaneously (incorrect route of product administration) (strength, dose number, anatomical location of injection, lot # and expiration date were not reported). No adverse effects were reported.
28NOV98 started itching on lower leg & then noted rash on both legs cont to get worst;3DEC98 seen by dermatologist sx on both lower legs & stomach;rash progressed up both legs;
second dose is scheduled 18 days post first dose; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose is scheduled 18 days post first dose) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypercholesterolemia (On cholesterol medicine.) and Blood pressure (Currently evaluated to see if she needs BP medication.).    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose is scheduled 18 days post first dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose is scheduled 18 days post first dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication included: Cholesterol medication, Potential BP medication.   Reporter did not allow further contact; Sender's Comments: This report refers to a case of Inappropriate Schedule Of Product Administration for mRNA-1273 (Lot number: 014M20A) with no associated AEs.
Patient had profuse diarrhea for 2 days requiring hospital admission for hydration. 1/8/09-records received for DOS 9/25-10/3/0-8-DC DX: Dehydration. Presented with C/O dehydration secondary to diarrhea, 2 day history of loose stool and irritability s/p received 4 month immunizations via G tube. Stools watery no blood or mucous. G tube to J tube conversion.
Arms are little sore; This is a spontaneous report from a contactable consumer (patient). This consumer reported similar events for two patients. This is one of the two reports.  A male patient of an unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) as dose 2, single, with route of administration and therapy date unspecified, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) on an unspecified date for COVID-19 immunization. On an unspecified date, after the second dose of vaccination, the patient's arms were a little sore. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number could not be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021202226 same reporter/product/events, different patient
circle around the vaccine site size of a tennis ball, swollen,; sleeve she noticed a red bump; swelling, feeling feverish just on the arm,; hot; circle around the injection site is size of tennis ball; patches of little bump; Sore arm; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Sore arm), VACCINATION SITE WARMTH (circle around the vaccine site size of a tennis ball, swollen,), ERYTHEMA (sleeve she noticed a red bump), PERIPHERAL SWELLING (swelling, feeling feverish just on the arm,) and FEELING HOT (hot) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included SERTRALINE, LOVASTATIN, METOPROLOL and OMEPRAZOLE for an unknown indication.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On an unknown date, the patient experienced VACCINATION SITE WARMTH (circle around the vaccine site size of a tennis ball, swollen,), ERYTHEMA (sleeve she noticed a red bump), PERIPHERAL SWELLING (swelling, feeling feverish just on the arm,), FEELING HOT (hot), VACCINATION SITE RASH (circle around the injection site is size of tennis ball) and RASH (patches of little bump). At the time of the report, PAIN IN EXTREMITY (Sore arm), VACCINATION SITE WARMTH (circle around the vaccine site size of a tennis ball, swollen,), ERYTHEMA (sleeve she noticed a red bump), PERIPHERAL SWELLING (swelling, feeling feverish just on the arm,), FEELING HOT (hot), VACCINATION SITE RASH (circle around the injection site is size of tennis ball) and RASH (patches of little bump) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided
she is immunocompromised; This is a spontaneous report from a non-contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 2, SINGLE and  via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was inquiring as to if she would be an appropriate candidate for a clinical trial we have. The patient has gotten both doses of the Pfizer vaccine. The patient stated that she was immunocompromised, and her doctor has written a letter that she was a candidate for a 3rd dose. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This case was reported by a nurse via call center representative and described the occurrence of fever in a male patient who received SHINGRIX for prophylaxis. Co-suspect products included FLUARIX QUADRIVALENT 2018-2019 season for prophylaxis. On 13th December 2018, the patient received the 1st dose of SHINGRIX (intramuscular) and FLUARIX QUADRIVALENT 2018-2019 season (intramuscular). On 13th December 2018, less than a day after receiving SHINGRIX and FLUARIX QUADRIVALENT 2018-2019 season, the patient experienced fever. On 14th December 2018, the outcome of the fever was recovered/resolved. It was unknown if the reporter considered the fever to be related to SHINGRIX and FLUARIX QUADRIVALENT 2018-2019 season. Additional details were provided as follows: The age at vaccination was not reported. The reporter was a retired nurse and also the mother in law of patient who received SHINGRIX along with a flu shot (unknown formulation). The patient experienced a fever of 102.2 degrees F at 8 PM that evening and that by the next day the fever resolved. The reporter did not wish to provide further specific information regarding the patient but stated she would encourage him to call back to provide more details.
pt devel mouth droop 4 days p/vax;couldn't close eye, face numb, dry rt eye;no pain;dx bells palsy;residual neuro deficit, facial droop & incomplete eye closure;
Patient initially experienced general muscle pain in the right deltoid after vaccine was given, which went away after a couple days. Pain in the patient's right shoulder has persisted since receiving vaccine. He is currently only experiencing pain if he lifts/extends his right arm. Describes pain as a mild/moderate pain, dependent on what direction/how far he extends his arm. Has not noticed considerable improvement since vaccine was given.
Burning, tingling from elbow to fingers. Slight numbness on left fingertips, especially the smallest finger. Felt better after resting and moving Left arm/hand. Stable, released from vaccination site.
Lymphatic swelling above collar bone and under arm pit.  A diameter of redness/rash around injection site.  It?s been 48 hrs.
Covid arm; pains, other pain; Headache; muscle aches; Fatigue; pain in the arm, in the area of the injection; fever of 99.8F°; chills; chest discomfort that  was not constant; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (chest discomfort that  was not constant), VACCINATION COMPLICATION (Covid arm), PAIN (pains, other pain), HEADACHE (Headache) and MYALGIA (muscle aches) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027h21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for COVID-19 vaccination: Pfizer in March 2021 and Pfizer.    On 03-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Dec-2021, the patient experienced CHEST DISCOMFORT (chest discomfort that  was not constant), VACCINATION SITE PAIN (pain in the arm, in the area of the injection), PYREXIA (fever of 99.8F°) and CHILLS (chills). On an unknown date, the patient experienced VACCINATION COMPLICATION (Covid arm), PAIN (pains, other pain), HEADACHE (Headache), MYALGIA (muscle aches) and FATIGUE (Fatigue). At the time of the report, CHEST DISCOMFORT (chest discomfort that  was not constant), VACCINATION COMPLICATION (Covid arm), PAIN (pains, other pain), HEADACHE (Headache), MYALGIA (muscle aches), FATIGUE (Fatigue), VACCINATION SITE PAIN (pain in the arm, in the area of the injection), PYREXIA (fever of 99.8F°) and CHILLS (chills) outcome was unknown.            No concomitant medication was reported. No treatment medication was reported.
Information has been received from a registered nurse, via a company representative, concerning a female patient (age not specified) who in October 2007 ("last week"), was vaccinated IM with a 0.5 ml dose of Gardasil.  Following the vaccination, the patient fainted, and received unspecified treatment in the office.  At the time of this report, the patient had recovered from the event (duration not specified).  Additional information has been requested.
No adverse effects reported.; an unspecified number of patients received improperly stored dose of RECOMBIVAX, GARDASIL 9, MMRII, or PROQUAD; The report was first received from a practice manager on 07-SEP-2018, and it was recognized as non-valid because report did not obtain any patient identify.  Follow-up information has been received from the practice manager on 18-SEP-2018.  This spontaneous report refers to a patient of unknown age and gender. Information of concurrent condition, medical history and concomitant therapy was not provided.       On 07-MAY-2018, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (recombinant Human albumin) (strength and route were unknown) (lot#  N020620 and expiration date 22-JAN-2019) for prophylaxis (Incorrect product storage). The sterile diluent (MERCK STERILE DILUENT) was properly stored. No adverse event was reported.  The excursion temperature on 22-SEP-2017, 17-OCT-2017, 06-DEC-2017, 07-DEC-2017, 30-JAN-2018, 23-FEB-2018, 18-MAY-2018, 05-JUL-2018, 15-AUG-2018 was 6 degree Celsius for maximize 8.75 hours. The excursion temperature on 02-MAR-2018, 27-AUG-2018 was 7 degree Celsius for maximize 8.75 hours. The excursion temperature on 07-DEC-2017 was 8 degree Celsius for maximize 15 hours. The call was not because of data logger.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1809USA003709: US-009507513-1810USA001951: US-009507513-1810USA001952: US-009507513-1810USA001953: US-009507513-1810USA001954: US-009507513-1810USA001955: US-009507513-1810USA001956: US-009507513-1810USA001957: US-009507513-1810USA001959:
Slept alot; Dizzy; Sweating; Nausea; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Slept alot), DIZZINESS (Dizzy), HYPERHIDROSIS (Sweating) and NAUSEA (Nausea) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SOMNOLENCE (Slept alot), DIZZINESS (Dizzy), HYPERHIDROSIS (Sweating) and NAUSEA (Nausea). At the time of the report, SOMNOLENCE (Slept alot), DIZZINESS (Dizzy), HYPERHIDROSIS (Sweating) and NAUSEA (Nausea) outcome was unknown.            No concomitant medications were reported.  No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not Applicable.